Chronic anticoagulation in atrial fibrillation

Dr TNews for Professionals, Professionals Leave a Comment

A few days ago I published an article called fatalities involving the new drug Dabigatran. This has resulted almost immediately in a letter from the Media Group Director of the PR company that handles advertising for the pharmaceutical firm involved. I am glad to post it here: Comment: “Just wanted to contact you with regard to your “Fatalities with Dabigatran and Warfarin …